SCHEMBL2289756

SCHEMBL2289756

CCC[N+](CC)(CC)S(=O)(=O)NC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL1827725 0.98
SCHEMBL2888595 0.87
Water SCHEMBL445436 0.87 MEN1 (0.31)
Water SCHEMBL3635067 0.85
SCHEMBL18480410 0.81 EPHX1 (0.32)
SCHEMBL13017382 0.68 ATM (0.37)
Water SCHEMBL117889 0.65 EPHX1 (0.31)
SCHEMBL5129198 0.64 CA1 (0.61)
SCHEMBL195067 0.63
SCHEMBL5874546 0.63 SLC22A1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110201581-A1 Novel Compounds 010 ASTRAZENECA AB (SE) 2011-08-18 US disclosed
US-5346893-A Treatment of transplantation rejection, autoimmune diseases; antiinflammatory agents AMERICAN HOME PRODUCTS CORPORATION (US) 1994-09-13 US disclosed
US-5260299-A Treats transplantation rejection, host versus graft disease and diseases of inflammation by administering in mammals AMERICAN HOME PRODUCTS CORPORATION (US) 1993-11-09 US disclosed
WO-1993018043-A1 NOVEL RAPAMYCIN 42-SULFONATES AND 42-(N-CARBOALKOXY)SULFAMATES USEFUL AS IMMUNOSUPPRESSIVE AGENTS AMERICAN HOME PRODUCTS CORPORATION (US) 1993-09-16 WO disclosed
US-5177203-A Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents AMERICAN HOME PRODUCTS CORPORATION (US) 1993-01-05 US disclosed